gvtcx

ANMI PSMA kit VEAT notice

The Royal Marsden NHS Foundation Trust Published 16 May 2022 Find a Tender

key details

Statuscomplete
Category (CPV) 33100000
Procedurelimited
OCIDocds-h6vhtk-0337ca

Award

SupplierValueDateStatus
Xiel Limited · · active

description

.The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer, disease progression or staging of cancer in UK.

There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 May 2022 Voluntary ex-ante transparency (F15) Earlier regulations 012588-2022

more from The Royal Marsden NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.